Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset.

Adverse drug reaction Cancer survivors Childhood cancer Cisplatin: carboplatin Drug-induced ototoxicity Genetic markers Multicenter cohort study Pharmacogenetics

Journal

Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 12 08 2020
accepted: 21 08 2020
entrez: 17 9 2020
pubmed: 18 9 2020
medline: 18 9 2020
Statut: epublish

Résumé

Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (

Identifiants

DOI: 10.1016/j.dib.2020.106227 PMID: 32939381 PMC: PMC7477761
pubmed: 32939381
doi: 10.1016/j.dib.2020.106227
pii: S2352-3409(20)31121-5
pii: 106227
pmc: PMC7477761
doi:

Types de publication

Journal Article

Langues

eng

Pagination

106227

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships which have, or could be perceived to have, influenced the work reported in this article.

Références

HNO. 2007 Apr;55(4):299-306
pubmed: 16437215
Acta Oncol. 2015 May;54(5):655-68
pubmed: 25813473
Eur J Cancer. 2018 Nov;103:227-237
pubmed: 30273888
JMIR Res Protoc. 2019 Mar 19;8(3):e11868
pubmed: 30888333

Auteurs

Thorsten Langer (T)

Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany.

Eva Clemens (E)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.

Linda Broer (L)

Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Lara Maier (L)

Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany.

André G Uitterlinden (AG)

Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.

Andrica C H de Vries (ACH)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.

Martine van Grotel (M)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Saskia F M Pluijm (SFM)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Harald Binder (H)

German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.

Benjamin Mayer (B)

Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.

Annika von dem Knesebeck (A)

Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany.

Julianne Byrne (J)

Boyne Research Institute, Drogheda, Ireland.

Eline van Dulmen-den Broeder (E)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Hematology and Oncology, VU Medical Center, Amsterdam, The Netherlands.

Marco Crocco (M)

Department of Neurooncology, Istituto Giannina Gaslini, Genova, Italy.

Desiree Grabow (D)

German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Peter Kaatsch (P)

German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Melanie Kaiser (M)

German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Claudia Spix (C)

German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Line Kenborg (L)

Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark.

Jeanette F Winther (JF)

Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark.
Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.

Catherine Rechnitzer (C)

Copenhagen University Hospital Rigshospitalet, Department of Pediatrics and Adolescent Medicine, Copenhagen, Denmark.

Henrik Hasle (H)

Aarhus University Hospital, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.

Tomas Kepak (T)

University Hospital Brno, Brno, Czech Republic, & International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic.

Anne-Lotte F van der Kooi (AF)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Obstetrics and Gynecology, Erasmus MC - Sophia Children's Hospital, The Netherlands.

Leontien C Kremer (LC)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.

Jarmila Kruseova (J)

Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic.

Stefan Bielack (S)

Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany.

Benjamin Sorg (B)

Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany.

Stefanie Hecker-Nolting (S)

Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany.

Claudia E Kuehni (CE)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Paediatric Oncology, Dept. of Paediatrics, Inselspital, University of Bern, Switzerland.

Marc Ansari (M)

Department of Pediatrics, Oncology and Hematology Unit, University Hospital of Geneva, Cansearch Research Laboratory, Geneva University, Switzerland.

Martin Kompis (M)

Department of Otolaryngology, Head and Neck Surgery, Inselspital, University of Berne.

Heleen J van der Pal (HJ)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.

Ross Parfitt (R)

Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany.

Dirk Deuster (D)

Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany.

Peter Matulat (P)

Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany.

Amelie Tillmanns (A)

Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany.

Wim J E Tissing (WJE)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Jörn D Beck (JD)

Hospital for Children and Adolescents, University of Erlangen-Nuremberg, Erlangen, Germany.

Susanne Elsner (S)

Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.

Antoinette Am Zehnhoff-Dinnesen (A)

Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany.

Marry M van den Heuvel-Eibrink (MM)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.

Oliver Zolk (O)

Institute of Clinical Pharmacology, Immanuel Klinik Rüdersdorf, Brandenburg Medical School Theodor Fontane, Germany.
Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany.

Classifications MeSH